Wang et al. [79] demonstrated an important translational aspect of the lipid metabolism regulation by cAMP/AMPK axis in mice: the PDE4 inhibitor rolipram increased the cAMP concentration and decreased senescence-associated adipose deposition and inflammation in the liver and kidney that were due to a metabolic disorder. This evidence concerns the gene PRKAA1 and metabolic disease.